YR
Yasmeen Rahimi Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
16
Avg Return
Past Year
Past Year
33%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
83.3%
Neutral
16.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $72 |
993%
upside
| 1 | -25% |
0
%
| 11 Nov ‘25 22 days ago |
|
|
|
Overweight
Maintained
| $36 |
222%
upside
| 1 | +0.98% |
0
%
| 28 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $540 |
7%
downside
| 1 | +33% |
0
%
| 15 Oct ‘25 1 month ago |
|
|
|
Overweight
Initiated
| $78 |
316%
upside
| 1 | +25% |
0
%
| 6 Oct ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $48 | – | 1 | – |
–
| 11 Sep ‘25 2 months ago |
|
|
|
Overweight
Initiated
| $20 |
118%
upside
| 1 | +53% |
0
%
| 8 Sep ‘25 2 months ago |
|